Every record from Medutest · page 13
Fast turnaround and the widest compound acceptance, at unit mass resolution rather than high resolution. Measured offset against the reference laboratory is +0.065 pp on 517 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-018498 | MOTS-c | WWB | WWB-2505-G2801 | 2025-Q3 | 99.88 | 2.75 | 105.7 | Supplier-supplied | 0 | PASS |
| AX-2025-020355 | Liraglutide | MKM | MKM-2508-P3929 | 2025-Q3 | 98.85 | 6.89 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020357 | Liraglutide | MKM | MKM-2508-P3929 | 2025-Q3 | 98.58 | 6.30 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-020192 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2507-S1153 | 2025-Q3 | 99.77 | 4.77 | 97.8 | Buyer-sourced | 2 | FAIL |
| AX-2025-019558 | Semaglutide | Homopeptide | HOMO-2506-M1846 | 2025-Q3 | 98.14 | 5.74 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020688 | Semaglutide | GL Biochem | GLBI-2505-V8283 | 2025-Q3 | 97.90 | 4.23 | 104.4 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-018687 | Dihexa | QYB | QYB-2503-Y6694 | 2025-Q3 | 99.93 | 7.58 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020607 | Retatrutide | SSA | SSA-2507-W7338 | 2025-Q3 | 97.54 | 3.37 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020305 | Ipamorelin | MKM | MKM-2504-N3425 | 2025-Q3 | 99.05 | 4.89 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020624 | BPC-157 | SSA | SSA-2505-J7223 | 2025-Q3 | 99.18 | 3.00 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020193 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2507-S1153 | 2025-Q3 | 99.93 | 5.24 | 93.1 | Supplier-supplied | 2 | FAIL |
| AX-2025-020896 | Semaglutide | CPC | CPC-2504-G2724 | 2025-Q3 | 98.53 | 5.05 | 103.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020775 | N-Acetyl Semax Amide | SGN | SGN-2505-Y9398 | 2025-Q3 | 98.87 | 6.86 | 100.6 | Buyer-sourced | 0 | PASS |
| AX-2025-020595 | Retatrutide | SSA | SSA-2508-N7223 | 2025-Q3 | 97.36 | 4.37 | 93.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019830 | Semaglutide | SWB | SWB-2504-Y4284 | 2025-Q3 | 99.72 | 3.40 | 94.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019034 | BPC-157 | JEEP | JEEP-2504-X2669 | 2025-Q3 | 98.13 | 7.38 | 95.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019432 | Semaglutide | Homopeptide | HOMO-2506-V8763 | 2025-Q3 | 98.51 | 5.78 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019295 | Selank | TFC | TFC-2504-G6596 | 2025-Q3 | 99.04 | 8.01 | 95.3 | Supplier-supplied | 0 | PASS |
| AX-2025-019119 | BPC-157 | JEEP | JEEP-2507-V4206 | 2025-Q3 | 99.93 | 5.26 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018716 | Tirzepatide | QSC | QSC-2502-P6653 | 2025-Q3 | 98.38 | 2.85 | 100.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020734 | Tirzepatide | SGN | SGN-2506-J8941 | 2025-Q3 | 96.30 | 2.22 | — | Buyer-sourced | 2 | FAIL |
| AX-2025-018820 | SS-31 (Elamipretide) | QSC | QSC-2502-M8050 | 2025-Q3 | 99.93 | 4.01 | 105.3 | Supplier-supplied | 0 | PASS |
| AX-2025-021007 | BPC-157 | WXT | WXT-2506-M3361 | 2025-Q3 | 99.07 | 3.43 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019833 | Semaglutide | SWB | SWB-2504-Y4284 | 2025-Q3 | 99.77 | 2.05 | 104.3 | Supplier-supplied | 0 | PASS |
| AX-2025-020121 | Retatrutide | GGPeps | GGPE-2508-E8992 | 2025-Q3 | 97.69 | 2.43 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019986 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 99.11 | 2.88 | 93.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021299 | CJC-1295 with DAC | BCH | BCH-2505-T7755 | 2025-Q3 | 99.25 | 8.36 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019316 | Retatrutide | TFC | TFC-2508-H7325 | 2025-Q3 | 98.04 | 3.52 | 93.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021242 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | 2025-Q3 | 97.62 | 6.55 | 97.3 | Buyer-sourced | 0 | FAIL |
| AX-2025-019460 | Retatrutide | Homopeptide | HOMO-2508-U9007 | 2025-Q3 | 99.17 | 5.73 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021054 | Semaglutide | WXT | WXT-2508-G4316 | 2025-Q3 | 98.53 | 2.86 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019041 | BPC-157 | JEEP | JEEP-2506-R3035 | 2025-Q3 | 99.53 | 2.54 | 106.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018669 | MK-677 (Ibutamoren mesylate) | QYB | QYB-2503-W6005 | 2025-Q3 | 99.08 | 4.63 | 97.4 | Supplier-supplied | 2 | FAIL |
| AX-2025-021059 | Liraglutide | WXT | WXT-2504-L4924 | 2025-Q3 | 96.70 | 5.85 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020642 | MOTS-c | SSA | SSA-2503-S7755 | 2025-Q3 | 99.39 | 5.01 | 89.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020251 | BPC-157 | GGPeps | GGPE-2502-U2458 | 2025-Q3 | 99.83 | 4.65 | 96.2 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-019989 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 99.14 | 3.57 | 91.2 | Supplier-supplied | 0 | PASS |
| AX-2025-019983 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 99.90 | 3.28 | 95.8 | Supplier-supplied | 0 | PASS |
| AX-2025-018873 | TB-500 | QSC | QSC-2505-B8934 | 2025-Q3 | 99.66 | 4.84 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020558 | Semaglutide | SSA | SSA-2502-U6796 | 2025-Q3 | 97.23 | 5.52 | — | Buyer-sourced | 2 | MARGINAL |